Implementing 90-90-90

Hands showing lab workers testing for HIV
A healthcare worker draws a drop of blood for an HIV test. Credit: UNICEF Ethiopia/ 2014/ Pudlowski

6442254013_7c77061ae0_bAll 52 districts in the country have developed district implementation plans (DIP) aimed at overcoming existing bottlenecks and fast tracking progress toward the 90-90-90 HIV and TB targets.

The DIP process is being driven by the the National Department of Health. The NDoH assists the districts and facilities to develop HIV, AIDS, STI and TB (HAST) plans and budgets that are a true reflection of operational needs through the bottom-up approach.

We focus on the worst performing indicators. Facilities and sub-districts have to draw up implementation plans to address these, rather than the usual national and provincial-led processes.

DIP process

Phase 1 of the DIP process in the 2015/16 financial year aimed to improve the performance of the three worst-performing district indicators through the re-allocation of existing budget to areas of greatest need.

We focus on the worst performing indicators. Facilities and sub-districts have to draw up implementation plans to address these, rather than the usual national and provincial-led processes.

Phase two involves identifying 12 poorly performing indicators – three indicators each from adult HIV, paediatric HIV, PMTCT and TB programmes.

Bottlenecks were analysed and facilities developed implementation plans to improve the performance of these indicators.

We are way ahead of anyone else in the world and at International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA) in Harare in 2015, other countries wanted our blueprint.

Viral load testing

We have been working with the National Health Laboratory Services (NHLS) to increase access to viral load tests. There are more viral load tests in South Africa than anywhere else on the continent. The problem is not with getting access to the test, but with getting people to get viral load tests every six months, ensure that the results are recorded and that there is clinical intervention if the viral load is not suppressed.

One of the challenges is loss to follow up, especially in the first three months after a person tests HIV positive. We have thus restructured counselling so that adherence  starts at the point of the test. Counsellors start to talk about treatment and adherence at the same time, and we are offering increased support in the first six months.

We are developing an app to remind people to take their medication and to go for their six-month viral load test. This is going to be customised for different groups – adolescents, women, men. We are already using MomConnect, a mobile service, to send messages to the cell phones of new moms.

High level of viral suppression

By the end of 2016/17 we aim to have around 800 000 people getting their medicine by courier.

Where we do have viral load tests, there is a high level of viral suppression – around 80 percent. Where a person’s viral load is undetectable and they are stable, we want to decant about 1.6 million patients into the Chronic Medicine Distribution Programme, so they can get their ARVs sent to them via courier.

By the end of 2016/17 we aim to have around 800 000 people getting their medicine by courier. If we can’t decant them and get their medicine to them, they will default when they don’t have transport money. It will also decrease the volume of patients on our facilities so that healthworkers can give more time to the patients that need to be there.

Dr Yogan Pillay is Deputy Director-General: HIV/AIDS, TB and Maternal, Child and Women’s Health in the National Department of Health, South Africa. This feature is taken from ‘Turn Around – The Story of South Africa’s HIV Response”, a book published by UNAIDS.

 

 

 

 

 

Author

Free to Share

Creative Commons License

Republish our articles for free, online or in print, under a Creative Commons license.


Related

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay in the loop

We love that you love visiting our site. Our content is free, but to continue reading, please register.

Newsletter Subscription